ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2017
Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015.
Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Guidelines for preoperative pulmonary function assessment in patients with lung cancer who will undergo surgery (The Japanese Association for Chest Surgery).General thoracic and cardiovascular surgery · 2025Guideline
- A systematic review of risk prediction models for perioperative mortality after thoracic surgery.Interactive cardiovascular and thoracic surgery · 2021Pooled it
- Surgical Interval as a Risk Factor for Postoperative Complications After Repeated Lung Cancer Resection: A Retrospective Cohort Study.Annals of thoracic surgery short reports · 2026Article
- Association between diaphragm thickness and postoperative complications in elderly patients with non-small-cell lung cancer.Surgery today · 2026Article
- Development of a machine learning-based risk model for postoperative complications of lung cancer surgery.Surgery today · 2024Article
- Salivary metabolites as potential predictive biomarkers for lung surgery complications: a retrospective cross-sectional study.Surgery today · 2024Article
- Impact of smoking on resected lung cancer depends on epidermal growth factor receptor mutation.Interdisciplinary cardiovascular and thoracic surgery · 2024Article
- Risk factors for bronchopleural fistula based on surgical procedure and sex in 4794 consecutive patients undergoing anatomical pulmonary resection.Surgery today · 2024Article
- Reintubation After Lung Cancer Resection: Development and External Validation of a Predictive Score.The Annals of thoracic surgery · 2024Article
- The surgical Apgar score predicts postoperative complications and the survival in lung cancer patients.Surgery today · 2023Article
- Risk factors for bronchopleural fistula after lobectomy for lung cancer.Journal of thoracic disease · 2023Article
- Postoperative mortality analysis on nationwide data from diagnosis procedure combination database in Japan.PloS one · 2023Article
- Mortality and lung function decline in patients who develop chronic pulmonary aspergillosis after lung cancer surgery.BMC pulmonary medicine · 2022Article
- Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.General thoracic and cardiovascular surgery · 2022Article
- Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.Breast cancer (Tokyo, Japan) · 2022Article
- Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.International journal of clinical oncology · 2022Article
- Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator.BMC surgery · 2022Article
- Predictive value of modified systemic inflammation score for postoperative unplanned ICU admission in patients with NSCLC.Frontiers in surgery · 2022Article
- A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan.Surgery today · 2022Article
- Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection.Surgery today · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesUsing data obtained from a Japanese nationwide annual database with web-based data entry, we developed a risk model of mortality and morbidity after lung cancer surgery.
methodsThe characteristics and operative and postoperative data from 80 095 patients who underwent lung cancer surgery were entered into the annual National Clinical Database of Japan data sets for 2014 and 2015. After excluding 1501 patients, the development data set for risk models included 38 277 patients entering in 2014 and the validation data set included 40 317 patients entering in 2015. Receiver-operating characteristic curves were generated for the outcomes of mortality and composite mortality/major morbidity. The concordance index was used to assess the discriminatory ability and validity of the model.
resultsThe 30-day mortality and overall mortality rates, including in-hospital deaths, were 0.4% and 0.8%, respectively, in 2014, and 0.4% and 0.8%, respectively, in 2015. The rate of major morbidity was 5.6% in 2014 and 5.6% in 2015. Several risk factors were significantly associated with mortality, namely, male sex, performance status, comorbidities of interstitial pneumonia and liver cirrhosis, haemodialysis and the surgical procedure pneumonectomy. The concordance index for mortality and composite mortality/major morbidity was 0.854 (P < 0.001) and 0.718 (P < 0.001), respectively, for the development data set and 0.849 (P < 0.001) and 0.723 (P < 0.001), respectively, for the validation data set.
conclusionsThis model was satisfactory for predicting surgical outcomes after pulmonary resection for lung cancer in Japan and will aid preoperative assessment and improve clinical outcomes for lung cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.